Ethical considerations and coping strategies for growth hormone therapy in children with short stature
10.12026/j.issn.1001-8565.2025.10.03
- VernacularTitle:生长激素治疗儿童矮身材的伦理考量与应对策略
- Author:
Yahong LIU
1
;
Fei WANG
1
;
Lijuan ZHANG
1
;
Hongxiao ZHANG
1
;
Yanfang ZHU
1
Author Information
1. Department of Pediatric Healthcare and Rehabilitation， the Second Hospital & Clinical Medical School， Lanzhou 730030， China
- Publication Type:Journal Article
- Keywords:
children;
growth hormone;
ethical consideration
- From:
Chinese Medical Ethics
2025;38(10):1246-1251
- CountryChina
- Language:Chinese
-
Abstract:
Height， as one of the crucial indicators for assessing children’s growth and development， has consistently been a global focus. With economic development and improvements in social living standards， the clinical management needs for children with short stature have been increasingly growing. While growth hormone brings hope to children with short stature， it also triggers ethical challenges such as medical standardization， expansion of indications， equitable accessibility， and informed consent. To avoid the ethical issues related to the use of pediatric growth hormone， multidimensional and comprehensive clinical management should be implemented for children with short stature， including strictly adhering to medical standards and ethical guidelines， enhancing public awareness， and promoting the standardized development of recombinant human growth hormone （rhGH） therapy and ethics.
